PA-001 (PeptiAID)

N/A

Report date: 2025/01/26 15:52:14

Base Information

Drug NamePA-001 (PeptiAID)
Drug Alias NameSARS-CoV-2 therapeutic (PeptiAID)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeptiAID Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiAID Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A